Distinct viral reservoirs and immune signatures in individuals on long-term antiretroviral therapy with perinatally acquired HIV-1

接受长期抗逆转录病毒治疗的围产期感染 HIV-1 的个体中存在独特的病毒库和免疫特征

阅读:7
作者:Benjamin Bone ,Nicola Cotugno ,Chiara Pighi ,Arianna Rotili ,Seohyun Hong ,Leah Carrere ,Elena Morrocchi ,Giuseppe Rubens Pascucci ,Ce Gao ,Nicole Colantoni ,Weiwei Sun ,Giovanna Leone ,David R Collins ,Mpho J Olatotse ,Giovanna Del Principe ,Toong Seng Tan ,Melanie Lancien ,Alessia Neri ,Libera Sessa ,Giulio Olivieri ,Kailey Shapiro ,Isabelle Roseto ,Catherine Koofhethile ,Elena Emili ,Stefania Bernardi ,Ann Chahroudi ,Paolo Rossi ,Bruce D Walker ,Xu G Yu ,Mathias Lichterfeld ,Paolo Palma

Abstract

Early initiation of antiretroviral therapy (ART) following HIV-1 infection restricts the size of the latent reservoir, following both horizontal and vertical infections. Here, we comprehensively profile the reservoirs and immunological milieus of nine young adults who acquired HIV-1 perinatally and remained on suppressive long-term ART (median: 20 years) since infancy (LeukoHIV cohort). Genome-intact reservoirs are markedly smaller compared to a cohort of adults on suppressive ART started in adulthood, with some LeukoHIV individuals characterized by an absence or near absence of intact proviruses in up to a billion peripheral blood mononuclear cells (PBMCs). Higher frequencies of functional CD56bright natural killer (NK) cells with increased cytotoxic activity are detectable in the LeukoHIV cohort compared to an adult reference cohort, while one LeukoHIV participant displayed a potent HIV-1-specific CD8+ T cell response. Collectively, our data suggest that long-term ART initiated in early life following perinatal transmission may facilitate an immune environment better equipped to restrict the HIV-1 reservoir.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。